Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-07-17

Clinical Trial Update: Beta-Cell Function of Insulin Glargine Compared to Neutral Protamine Hagedorn (NPH) Insuline and to Insulin Detemir in Combination With Metformin [Phase 4]

View source ↗

Summary

This Phase 4 trial reports on beta-cell function when using insulin glargine compared with NPH insulin and with insulin detemir, each in combination with metfor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin Glargine (insulin glargine)
  • Insulin detemir (insulin detemir)
  • NPH insulin (insulin isophane)

Snippet

Sponsor: ikfe-CRO GmbH | Conditions: Type 2 Diabetic Patients, Insufficient Metabolic Control | Phase 4 | Status: COMPLETED